LITERATURE REVIEW AND ANALYSIS OF CASE SERIES USING RECOMBINANT HUMAN THYROTROPIN ALFA IN PATIENTS WITH DIFFERENTIATED THYROID CANCER
The paper presents the results of treatment of 15 patients DTC with the drug rhTSH before radioiodine therapy. The use of rhTSH preparation is the method of choice in patients with low levels of endogenous TSH (46.6 % in 15 patients) and in patients with bilateral paresis of the vocal folds (20 %). The use of rhTSH preparation significantly improves the quality of life of patients DTC due to the lack of clinical signs of hypothyroidism (33,4 %).